• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    France Brucellosis Market

    ID: MRFR/LS/51831-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    France Brucellosis Market Research Report By species (Brucella suis, B

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    France Brucellosis Market Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    France Brucellosis Market Summary

    The France Brucellosis market is projected to grow significantly from 9.3 USD Million in 2024 to 27.9 USD Million by 2035.

    Key Market Trends & Highlights

    France Brucellosis Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 10.5% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 27.9 USD Million, indicating robust growth potential.
    • In 2024, the market is valued at 9.3 USD Million, reflecting the current state of Brucellosis management in France.
    • Growing adoption of advanced diagnostic technologies due to increased awareness of Brucellosis is a major market driver.

    Market Size & Forecast

    2024 Market Size 9.3 (USD Million)
    2035 Market Size 27.9 (USD Million)
    CAGR (2025-2035) 10.5%

    Major Players

    Intervet, IDEXX Laboratories, Boehringer Ingelheim Vetmedica, Diamond Animal Health, Vetoquinol, Neogen Corporation, Heska Corporation, Merck Animal Health, AgriLabs, Boehringer Ingelheim, Ceva Santé Animale, Virbac, Elanco Animal Health, Phibro Animal Health, Zoetis

    France Brucellosis Market Trends

    The market for brucellosis in France is undergoing a number of noteworthy trends that are being fueled by both regulatory actions and public health concerns. The growing awareness of zoonotic diseases, particularly brucellosis, which affects cattle and can be spread to people, is one of the main factors propelling the market.

    Stricter monitoring and vaccination campaigns are the result of the French government's aggressive efforts to prevent and eradicate brucellosis, especially in cattle and sheep. A greater understanding of the public health hazards posed by brucellosis outbreaks, which can have a serious effect on both human and animal populations, is reflected in this proactive approach.

    Possibilities in France The market for brucellosis includes developments in vaccination and diagnostic technology as well as the possibility of more funding for research projects. Research institutes, veterinary groups, and government organizations working together can promote innovation in brucellosis prevention and treatment, opening the door to better management approaches.

    Furthermore, there is potential for creating educational initiatives aimed at farmers and veterinarians to raise knowledge of early identification and preventive actions as the industry develops. Additionally, recent patterns show a move toward more integrated methods to brucellosis management, combining community involvement, public health tactics, and animal health management.

    Sustainable farming methods that support animal welfare and successfully control disease risks are the main emphasis of the French agricultural industry. This comprehensive approach paves the path for a coordinated response to brucellosis and is in line with larger European Union goals pertaining to food safety and animal disease prevention.

    In light of these developments, it is clear how important it is for France to work together to address the problems caused by brucellosis in order to eventually eradicate and better control the illness.

    Market Segment Insights

    France Brucellosis Market Segment Insights

    France Brucellosis Market Segment Insights

    Brucellosis Market species Insights

    Brucellosis Market species Insights

    The France Brucellosis Market is significantly influenced by various species of Brucella, each playing a critical role in the dynamics of the market. Brucella suis is known for its impact on swine, which is a vital part of France's agricultural landscape, contributing to the country's meat production industry.

    The presence of B. suis poses a challenge for livestock health, impacting the supply chain and food safety concerns related to pork products. Meanwhile, B. abortus primarily affects cattle, which are fundamental to France’s dairy and beef industries.

    The management and control of this species are essential to sustain the economic stability and growth of these sectors. Furthermore, B. melitensis is often associated with sheep and goats, contributing to the dairy market, especially in regions where these livestock products are prominent.

    The prevalence of this species highlights the need for adequate veterinary services and biosecurity measures in agricultural practices. Overall, the significance of these Brucella species in the France Brucellosis Market is underscored by their influence on livestock health, public health implications, and the associated economic factors within the agriculture industry.

    Get more detailed insights about France Brucellosis Market Research Report- Forecast To 2035

    Key Players and Competitive Insights

    The France Brucellosis Market is characterized by a dynamic and competitive landscape, driven by factors such as the increasing incidence of brucellosis among livestock, the growing awareness of animal health among farmers, and stringent government regulations aimed at disease control.

    This market comprises various players offering vaccines, diagnostic kits, and treatments specifically designed to tackle brucellosis in cattle, sheep, and goats.

    Competitive dynamics are influenced by ongoing research and development activities, partnerships for product innovation, and the need for effective disease management solutions. Players in the market are focusing on enhancing product efficacy and developing new technologies to stay ahead in this niche field.

    Intervet plays a crucial role in the France Brucellosis Market, offering a variety of vaccines and diagnostic solutions tailored for the prevention and management of brucellosis in livestock. The company is known for its strong reputation and commitment to research and development, which enables it to provide innovative products that address the specific needs of farmers in France.

    Intervet's established network of distribution channels ensures its products are readily available to veterinary practitioners and livestock producers across the region. Moreover, the company is recognized for its collaboration with local agricultural organizations, which enhances its presence and strengthens its market position.

    Intervet's focus on high-quality products and customer education further underpins its competitive edge, as it works to effectively influence the management of health within the livestock sector.

    IDEXX Laboratories holds a prominent position within the France Brucellosis Market, recognized for its extensive portfolio of diagnostic tests and services aimed at early detection and management of brucellosis.

    The company offers key products that facilitate accurate and timely diagnosis, allowing veterinarians to implement effective treatment plans. IDEXX Laboratories’ strong market presence is bolstered by its commitment to research in veterinary diagnostics, which has led to innovative solutions that cater specifically to the needs of the French livestock industry.

    Their focus on maintaining high standards of quality and reliability in testing contributes to their solid reputation among veterinarians and livestock managers.

    IDEXX Laboratories has also pursued strategic partnerships and acquisitions to enhance its capabilities, resulting in a broader range of services available to its customers in France, thus solidifying its competitive advantage in this critical sector of animal health.

    Key Companies in the France Brucellosis Market market include

    Industry Developments

    In recent developments, the France Brucellosis Market has seen heightened activity, particularly with companies such as Intervet, IDEXX Laboratories, and Boehringer Ingelheim Vetmedica focusing on enhancing their veterinary solutions to combat brucellosis.

    As of August 2023, France has reported an increase in brucellosis cases in livestock, prompting government agencies to reinforce vaccination and monitoring programs. This rise in disease incidence has resulted in a push for innovations in diagnostics and treatments, namely by firms such as Merck Animal Health and Zoetis, which are investing in Research and Development to develop more effective vaccines and diagnostic kits.

    Moreover, recent acquisitions have also shaped the landscape, with Boehringer Ingelheim announcing in July 2023 a strategic acquisition aimed at boosting their portfolio in animal health specifically targeting infectious diseases including brucellosis.

    The market has seen significant growth, with companies like Elanco Animal Health and Virbac expanding their operations in France to cater to the increasing demand for brucellosis management solutions.

    Over the last two to three years, the market has consistently responded to epidemiological trends, adjusting product offerings and improving surveillance mechanisms, indicating a proactive approach by major players in the France Brucellosis Market.

    Market Segmentation

    Brucellosis Market species Outlook

    • Brucella suis
    • B. abortus
    • B. melitensis

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 8.54(USD Million)
    MARKET SIZE 2024 9.3(USD Million)
    MARKET SIZE 2035 27.9(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 10.503% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Intervet, IDEXX Laboratories, Boehringer Ingelheim Vetmedica, Diamond Animal Health, Vetoquinol, Neogen Corporation, Heska Corporation, Merck Animal Health, AgriLabs, Boehringer Ingelheim, Ceva Santé Animale, Virbac, Elanco Animal Health, Phibro Animal Health, Zoetis
    SEGMENTS COVERED species
    KEY MARKET OPPORTUNITIES Increased vaccination programs, Enhanced diagnostic technologies, Government health initiatives, Rising livestock health awareness, Growth in veterinary healthcare services
    KEY MARKET DYNAMICS increasing zoonotic disease awareness, regulatory health measures, rising livestock vaccination programs, advancements in diagnostic technologies, growing veterinary healthcare expenditure
    COUNTRIES COVERED France

    FAQs

    What is the projected market value of the France Brucellosis Market in 2024?

    The projected market value of the France Brucellosis Market in 2024 is expected to be 9.3 USD Million.

    What is the expected market value of the France Brucellosis Market by 2035?

    By 2035, the France Brucellosis Market is expected to reach a value of 27.9 USD Million.

    What is the expected CAGR for the France Brucellosis Market from 2025 to 2035?

    The expected CAGR for the France Brucellosis Market from 2025 to 2035 is 10.503 percent.

    Who are the key players in the France Brucellosis Market?

    Key players in the France Brucellosis Market include Intervet, IDEXX Laboratories, Boehringer Ingelheim Vetmedica, and more.

    What is the market value of Brucella suis in 2024 and 2035?

    Brucella suis is valued at 2.5 USD Million in 2024 and is expected to reach 7.5 USD Million by 2035.

    How much is the B. abortus market valued at in 2024 and 2035?

    The B. abortus market is valued at 3.0 USD Million in 2024 and is projected to be 9.0 USD Million by 2035.

    What is the expected market value for B. melitensis in 2024 and 2035?

    The market value for B. melitensis is expected to be 3.8 USD Million in 2024 and 11.4 USD Million in 2035.

    What growth rate can be expected for the France Brucellosis Market?

    The France Brucellosis Market is expected to grow significantly during the forecast period from 2025 to 2035.

    What are the emerging trends in the France Brucellosis Market?

    Emerging trends in the France Brucellosis Market include advancements in diagnostic technologies and increasing focus on livestock health.

    What challenges may impact the France Brucellosis Market growth?

    Challenges impacting growth in the France Brucellosis Market include regulatory hurdles and public awareness about animal diseases.

    France Brucellosis Market Research Report- Forecast To 2035 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Stories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study
    Chemicals and Materials